MASTL is enriched in cancerous and pluripotent stem cells and influences OCT1/OCT4 levels

Elisa Närvä, Maria E. Taskinen, Sergio Lilla, Aleksi Isomursu, Mika Pietilä, Jere Weltner, Jorma Isola, Harri Sihto, Heikki Joensuu, Sara Zanivan, Jim Norman, Johanna Ivaska

iScience (2022)

Published on December 3, 2025

DOI: https://doi.org/10.1016/j.isci.2022.104459

← Back to Publications
I. Tamanna et al. • Aug 10, 2026 • Journal of Proteome Research
Abstract Food residues that bypass human digestion are further digested by gut microbes, leading to the production of diverse metabolites,...
J. Grist et al. • May 4, 2026 • Journal of Neuroinflammation
Abstract Given the prevalence of metabolic perturbations in a variety of neurological and neurodegenerative diseases, understanding and monitoring brain metabolism...
M. Gluud et al. • Mar 8, 2026 • Allergy
ABSTRACT Background Skin barrier dysfunction is central to inflammation and susceptibility to infection in atopic dermatitis (AD). Cutaneous T‐cell lymphoma...